TRIBE Clinical Research

10/16/2026

October is Health Literacy Month!

At Tribe Clinical Research, we believe informed patients are empowered patients. Asking questions and understanding your options are important steps in making confident healthcare decisions.

Our latest blog highlights the importance of health literacy in clinical research and why your questions matter!

Read more here: https://tcr-sc.com/octoberblog or at the link in our bio.

10/14/2026

Hearing directly from our patients is such a meaningful part of what we do. We’re proud to support their journey and advance research that makes a difference.

If you’ve ever been interested in clinical research, visit our website to learn how you can help advance the future of medicine—and become a hero of hope!

Visit Here: https://tcr-sc.com/participant

10/13/2026

Are you currently on a weekly GLP-1 RA (semaglutide or tirzepatide) for weight management? Explore a clinical trial evaluating a monthly GLP-1 RA investigational study medicine.

Maintaining your weight loss success may be easier. We are researching whether switching to monthly doses of the investigational study medicine can help people keep their weight off over time.

Qualifications:
- Adults 18+
- Do not have type 2 diabetes
- Currently receiving weekly doses of a GLP-1 for weight management
- Additional qualifications discussed during screening

Learn more and see if you may qualify:
🔗https://tcr-sc.com/GLPswitch

Contact us today to learn more.
📞 864.334.0141
📧 [email protected]

Qualified participants only. Study subject to change without notice. No cost to participate. Compensation may be available for time and travel.

10/08/2026

Parents of toddlers, we’d love your help advancing RSV research!

RSV is a very common respiratory virus that can cause cold-like symptoms, but in some young children, it can lead to more serious breathing problems.

Tribe Clinical Research is enrolling children ages 12–30 months in a clinical study evaluating an investigational nasal spray RSV vaccine.

Important note: Participation is open to anyone who meets the eligibility criteria—your child does not have to be a Parkside Pediatrics patient to enroll.

Some children may have previously received an RSV antibody injection as babies. That is different from this nasal spray vaccine study, and your child may still qualify.

✔ No cost to participate
✔ Compensation up to $3,500

Interested in learning more or seeing if your child may qualify?
🔗 tcr-sc.com/rsv
📧 [email protected]
📞 (864) 334-0141
🌐 TribeClinicalResearch.com

The future of medicine begins with you.

Qualified participants only. Study subject to change without notice. No cost to participate. Compensation may be available.

10/07/2026

Meet the People Behind the Trials

Clinical trials are built on science—and powered by people.

TribeClinicalResearch.com

10/07/2026

Our own Dr. Scott Dobson recently joined WYFF 4 to discuss an innovative flu vaccine study that is now enrolling at our Greer and Spartanburg locations. We're proud to bring cutting-edge research opportunities to our community and help advance the future of medicine while supporting healthier futures for older adults.
To watch his interview with WYFF 4, visit this link: https://tcr-sc.com/flunews

WYFF News 4

Are you interested in participating in a clinical trial? Do you want to learn more? Please complete the form below, and we will contact you soon to talk about the trial and qualifications.

10/05/2026

This clinical research study is evaluating a potential treatment option for children and adolescents living with migraines. If your child is between the ages of 6 and 17 and has been diagnosed with migraines for more than 6 months, they may qualify to participate.

By joining this study, your family can help advance research that may benefit children affected by migraines now and in the future. This study is currently enrolling at Tribe Clinical Research in Greenville.

Have questions or interested in learning more? Visit this link: https://tcr-sc.com/pedsmigraine

📞 864.334.0141
📧 [email protected]
🔗 https://tcr-sc.com/migraine

The future of medicine begins with you.
Qualified participants only. Compensation up to $900 may be available. Study subject to change without notice.

10/02/2026

We’re excited to introduce John Humeniuk, MD, the newest Principal Investigator at Tribe Clinical Research!

Throughout his career, Dr. Humeniuk has prioritized research and stayed at the forefront of emerging treatments with the goal of improving patients’ lives and making care less burdensome.

After retiring from private practice, Dr. Humeniuk is continuing his commitment to advancing medicine by joining the Tribe team, with a particular focus on dermatology research.

We’re excited to welcome Dr. Humeniuk to the Tribe and look forward to the experience, knowledge, and passion for research he brings to our patients and team.

09/30/2026

We can't wait for tomorrow night! Come out and join us for some fall family fun!

09/30/2026

Your heart health matters, and your participation could help shape the future of heart care.

Tribe Clinical Research is currently enrolling patients for multiple clinical studies focused on heart health and cardiovascular conditions.

Our studies are exploring areas such as high blood pressure, heart disease risk, cholesterol and triglycerides, and other factors that can impact cardiovascular health.

Qualified patients receive study-related care at no cost, and compensation may be available for time and travel.

Interested in learning more? Visit: https://tcr-sc.com/hearthealth1

Study subject to change without notice. Compensation Available for time and travel.

The future of medicine begins with you.